In this article, we will discuss the 10 stocks whose price targets were recently trimmed by analysts.
Equity markets in Asia demonstrated widespread gains on January 19, mirroring the positive trend in Nasdaq 100 futures, propelled by the optimistic outlook of Taiwan Semiconductor Manufacturing Co. (TSMC). The surge in semiconductor stocks contributed to the upward momentum of MSCI Inc.’s Asia Pacific index for the second consecutive day. TSMC, in particular, experienced a remarkable increase of over 6% in Taiwan, while its American depository receipts saw an impressive surge of nearly 10%, reaching the highest closing level since February 2022. The noteworthy performance of TSMC has become a focal point, acting as a catalyst for heightened expectations of a global recovery within the semiconductor sector. The positive momentum in Asia reflects the broader sentiment in equity markets, driven by the resilience and growth potential perceived in key industry players. Traders’ sentiments are undergoing shifts, with a notable reduction in bets on a Federal Reserve rate cut anticipated in March. This adjustment in expectations aligns with the evolving economic landscape and signals a degree of confidence in the prevailing economic conditions. Redmond Wong, Chief China Strategist, provided insights into the outlook for the world’s second-largest economy, shedding light on government policies and their implications for the stock markets. These discussions underscore the importance of staying informed about global economic dynamics and geopolitical factors that influence market trends. As markets continue to respond to changing conditions, the performance of semiconductor stocks, such as TSMC, serves as a barometer for broader economic recovery sentiments. Investors and analysts will closely monitor developments in the semiconductor sector and gauge their impact on global markets in the coming days.
According to Reuters, the most recent economic indicators point towards a positive trajectory for the U.S. economy as of January 18, with notable developments in jobless claims and the housing market. Weekly jobless claims have reached a 16-month low, falling by 16,000 to 187,000, showcasing a robust labor market. The decline, unexpected by economists, hints at sustained job growth in January and contributes to an optimistic economic outlook, potentially complicating expectations for a Federal Reserve interest rate cut in March. The strong performance is attributed to the resilience of the labor market, where companies are demonstrating reluctance to lay off workers amidst challenges in finding skilled labor, particularly after the COVID-19 pandemic. Though some volatility in claims data is expected during the turn of the year, the overall trend aligns with a tight labor market. In the housing sector, single-family housing starts experienced an 8.6% decline in December, attributed in part to adverse weather conditions. However, the year-on-year increase of 15.8% indicates sustained demand, fueled by a shortage of existing homes for sale. Building permits for single-family homes rose by 1.7% to the highest level since May 2022, reflecting positive sentiment among homebuilders and responding to declining mortgage rates. While the housing market shows signs of resilience and increased demand for new construction, challenges persist, particularly in addressing the inventory shortage. The gap between housing starts and completion rates and the inventory gap in the market underscore the need for additional supply to alleviate the housing affordability crisis. Overall, these economic indicators provide a multifaceted view of the U.S. economy’s current state, with both the labor market and the housing sector contributing to a generally positive narrative. Investors and analysts will closely monitor these trends for insights into economic resilience and potential policy implications.
On the stock market front, analysts are bearish on The Procter & Gamble Company (NYSE:PG) and Tesla, Inc. (NASDAQ:TSLA) by trimming their price targets. Check out the complete article to see details of these stocks.
Rawpixel.com/Shutterstock.com
10. Caesars Entertainment, Inc. (NASDAQ:CZR)
Price Reaction after the Price Target Cut: +2.34 (+5.30%)
As of January 18, Stifel analyst Steven Wieczynski has made adjustments to the outlook for Caesars Entertainment, Inc. (NASDAQ:CZR), a significant player in the gaming and entertainment industry. Despite lowering the price target from $70.00 to $67.00, Wieczynski maintains a buy rating on the stock. Following this price target cut, the closing bell on January 18 witnessed a price reaction, with Caesars Entertainment, Inc. experiencing a positive uptick of +2.34 (+5.30%). This shift in the price target and subsequent market response highlights the dynamic nature of financial assessments and investor reactions within the gaming and entertainment sector. Wieczynski’s decision to maintain a buy rating indicates an underlying confidence in Caesars Entertainment, Inc. potential for growth and value appreciation, even with a revised price target.
Baron Real Estate Fund made the following comment about Caesars Entertainment, Inc. in its second quarter 2023 investor letter:
“In the most recent quarter, we reduced our investment in Caesars Entertainment, Inc. (NASDAQ:CZR), the largest casino-entertainment company in the U.S. and one of the world’s most diversified casino-entertainment providers. We chose to modestly reduce our significant exposure in travel-related real estate companies and reallocated the capital to other non-travel related real estate companies. We are big fans of CEO Tom Reeg and remain optimistic about the long-term prospects for the company.”
09. The Boeing Company (NYSE:BA)
Price Reaction after the Price Target Cut: +8.55 (+4.21%)
Just like The Procter & Gamble Company and Tesla, Inc., analysts are bearish on The Boeing Company (NYSE:BA). As of January 18, Susquehanna analyst Charles Minervino has revised his evaluation of The Boeing Company, a major player in the aerospace and aviation industry. Despite lowering the price target from $306 to $279, Minervino maintains a Positive rating on the stock. Following this adjustment, the closing bell on January 18 witnessed a notable price reaction, with The Boeing Company experiencing a positive increase of 4.21%. The market’s reaction, characterized by a notable increase in stock value, adds an interesting dimension to The Boeing Company ongoing narrative within the aerospace and aviation industry. This development reflects the ongoing dynamics within the aerospace and aviation sector, where analysts like Minervino are recalibrating their expectations for individual stocks based on various factors. Despite the reduced price target, maintaining a Positive rating suggests that Minervino sees The Boeing Company as having favorable prospects for growth and value appreciation.
08. Starbucks Corporation (NASDAQ:SBUX)
Price Reaction after the Price Target Cut: +1.57 (+1.71%)
On January 18, Wedbush analyst adjustments significantly influenced the evaluation of Starbucks Corporation (NASDAQ:SBUX), a key player in the coffee and beverage industry. Despite a reduction in the price target from $100 to $95, the analyst maintains a Neutral rating on the stock. This modification, coupled with the note highlighting “increasingly limited top-line visibility,” adds an additional layer of consideration. Following this alteration, the closing bell on January 18 witnessed a modest price reaction, with Starbucks Corporation experiencing a positive uptick of 1.71%. This development sheds light on the evolving dynamics within the coffee and beverage sector, where analysts like Wedbush are adjusting their outlooks based on various considerations. The mention of “increasingly limited top-line visibility” suggests a heightened awareness of challenges and uncertainties facing Starbucks Corporation in terms of revenue generation.
RiverPark Advisors made the following comment about Starbucks Corporation in its Q3 2023 investor letter:
“Starbucks Corporation (NASDAQ:SBUX): SBUX is the premier roaster, marketer and retailer of specialty coffee in the world, operating in 83 markets. Through its more than 36,000 global stores (roughly 50% operated and 50% licensed) the company offers handcrafted coffee, tea and other beverages and a variety of food items. SBUX also sells a variety of packaged coffee and tea products and licenses its trademarks through other channels such as grocery and foodservice through a Global Coffee Alliance with Nestlé. In addition to its flagship Starbucks Coffee brand, the company sells goods and services under the brands Teavana, Seattle’s Best Coffee, Ethos, Starbucks Reserve and Princi.
SBUX’s recently appointed CEO (March 2023), Narasimhan Laxman, reiterated the company’s long-term plans for 10-12% revenue growth and 15-20% EPS growth while reporting fiscal 3Q23 earnings. Revenue will be driven by a combination of factors including unit growth, higher food “attach” rates (more food sold per cup of coffee), equipment innovation to speed throughput, and delivery expansion. In addition to the leverage of higher revenue across the company’s fixed asset base, SBUX sees margin expansion from supply chain management opportunities and procurement efficiencies. We initiated a small position in August.”
07. Cummins Inc. (NYSE:CMI)
Price Reaction after the Price Target Cut: +0.11 (+0.05%)
On January 18, JPMorgan Chase & Co. made significant revisions to its evaluation of Cummins Inc. (NYSE:CMI), a key player in the manufacturing and engine technology industry. The financial institution lowered the price target from $255.00 to $245.00 while maintaining an Underweight rating on the Cummins Inc. stock. Following this adjustment, the closing bell on January 18 witnessed a marginal price reaction, with Cummins Inc. experiencing a modest uptick of 0.05%. This development sheds light on the shifting dynamics within the manufacturing and engine technology sector, where financial analysts such as JPMorgan Chase & Co. are fine-tuning their assessments based on various considerations. Despite the reduction in the price target, maintaining an Underweight rating suggests a cautious stance, reflecting the analyst’s opinion that Cummins Inc. may underperform compared to its industry peers. Similar to how analysts express a bearish sentiment on The Procter & Gamble Company and Tesla, Inc., Cummins Inc. is also viewed pessimistically by analysts.
06. Diamondback Energy, Inc. (NASDAQ:FANG)
Price Reaction after the Price Target Cut: -0.04 (-0.03%)
As of January 18, BofA Securities made significant adjustments to its evaluation of Diamondback Energy, Inc. (NASDAQ:FANG), a notable player in the energy exploration and production industry. The financial institution reduced the price target from $147 to $129 while maintaining an Underperform rating on the Diamondback Energy, Inc. stock. In response to this revision, the closing bell on January 18 witnessed a marginal negative price reaction, with Diamondback Energy, Inc. registering a slight decline of 0.03%. Despite the reduction in the price target, the decision to uphold an Underperform rating underscores a bearish stance, indicating the belief that Diamondback Energy, Inc. may underperform compared to industry peers.
Diamond Hill Large Cap Strategy made the following comment about Diamondback Energy, Inc. in its Q3 2023 investor letter:
“Diamondback Energy, Inc. (NASDAQ:FANG) is a top-tier operator in the independent US E&P sector, running a streamlined team with an organizational culture centered on efficiency and cost-optimization. Its strategic location in Midland, Texas, close to its Permian operations, gives it a unique advantage by being in close proximity to a community of service providers. This has helped the company optimize its operations and reduce costs. The company stands out as a pure play in the Permian region, demonstrating strong operational capabilities, a sound capital return framework and a history of intelligent capital allocation. As long-term investors, we appreciate Diamondback’s strategic approach to investment and its commitment to cost efficiency and sustainable growth.”
05. The Procter & Gamble Company (NYSE:PG)
Price Reaction after the Price Target Cut: -0.86 (-0.58%)
On January 18, JPMorgan Chase & Co. implemented substantial adjustments to its evaluation of The Procter & Gamble Company, a major player in the consumer goods industry. The financial institution lowered the price target from $169.00 to $162.00 while maintaining an “overweight” rating on the stock. In response to this revision, the closing bell on January 18 witnessed a notable negative price reaction, with The Procter & Gamble Company experiencing a decline of 0.58%. Despite the reduction in the price target, the decision to retain an “overweight” rating suggests a positive outlook, indicating the belief that The Procter & Gamble Company may outperform relative to its industry peers.
Hayden Capital made the following comment about The Procter & Gamble Company in its third 2023 investor letter:
“It’s not just emerging markets either, where one could argue a “scarcity premium” given fewer quality public companies. Even in the US, Coca-Cola trades at ~30x P/E despite having the same earnings as 10 years ago. The Procter & Gamble Company (NYSE:PG) is likewise at ~27x P/E, with earnings only ~12% higher than a decade ago (or a ~1% annual growth rate). This equates to a mere 3.3% – 3.7% earnings yield.
Both of these companies actually have lower revenues than 10 – 15 years ago too, indicating that their profit growth is mostly from margin expansion. This can only last for so long before there’s no more excess expenses left to cut.
I find it ironic that all these companies trade as “bond-equivalents” in the minds of investors – even commanding lower yields than US treasuries, the safest security in the world. But it’s clear that their businesses are not nearly as safe. Proctor & Gamble is facing disruption from direct-to-consumer brands that offer their products for a fraction of the price.
But these companies are ~35% more expensive than US Treasuries, despite the heightened risk. On a risk-adjusted basis, one could argue the implied premium is even higher.
Perhaps the explanation is simply the price volatility difference between these stocks and treasuries over the last two years. For example, 10-year Treasury bonds are down ~-20% since the beginning of 2022. By comparison, KO and PG are remarkably down only -4 – 6% over that time frame.”
04. The Charles Schwab Corporation (NYSE:SCHW)
Price Reaction after the Price Target Cut: -0.73 (-1.15%)
On January 18, Barclays analyst Benjamin Budish made significant adjustments to the evaluation of The Charles Schwab Corporation (NYSE:SCHW), a key player in the financial services industry. Budish lowered the price target from $68.00 to $64.00 while maintaining an “equal weight” rating on the stock. Following this revision, the closing bell on January 18 witnessed a notable negative price reaction, with The Charles Schwab Corporation experiencing a decline of 1.15%. Despite the reduction in the price target, the decision to uphold an “equal weight” rating suggests a neutral stance, indicating that The Charles Schwab Corporation is expected to perform in line with industry peers. The significant negative market response observed on January 18 adds depth to The Charles Schwab Corporation ongoing narrative within the financial services industry.
Right Tail Capital stated the following regarding The Charles Schwab Corporation in its fourth quarter 2023 investor letter:
“Some of Right Tail’s larger investment decisions this year involved moving on from an investment. Charlie would say don’t avoid mistakes because they are inevitable. Instead, focus on repeating what works.
Notably, I sold The Charles Schwab Corporation (NYSE:SCHW) in March. Now that some time has passed, I’ll share how I approached the decision. In March, Charles Schwab stock declined ~25% during the banking challenges that crippled First Republic Bank and Silicon Valley Bank. Schwab has some similarities in that it is a bank (investing idle cash in their customers’ accounts allows them to charge less for other products and services) and had invested in bonds during the low interest rate years that would be worth less if Schwab needed to liquidate today. Also, Schwab clients were leaving less cash in their accounts favoring higher interest alternatives that were a more expensive cost of funds for Schwab. However, Schwab had many positives relative to the troubled banks such as limited uninsured deposits and sticky assets. For example, investment advisors such as Right Tail who custody at Schwab have limited options. It would be a hassle (though quite doable) to switch to a different custodian (and I would absolutely make the change if I thought it was in the best interest of our investors). I carefully considered the pros and cons. Something had changed in that I had always considered Schwab to be a beneficiary of rising interest rates – now the company was rooting for lower rates in the intermediate term. I thought Schwab may have to raise capital to deal with their short-term liquidity challenges (they indirectly raised capital by pausing their stock repurchase program). I also thought regulators may ask more of Schwab as an important institution that no one wants to fail. Positively, I was still rooting for Schwab and thought they’d continue to be a blue chip brokerage firm that would likely keep taking share over time.
Ultimately, I felt my time and energy would be better spent trying to find the next great Right Tail investment than in trying to untangle Schwab. I sold the stock in the mid to high $50s and used the proceeds to add to our existing positions that I felt best about. I estimate that owning Schwab reduced our returns by less than 100 bps since inception and ~250 bps for 2023.”
03. Tesla, Inc. (NASDAQ:TSLA)
Price Reaction after the Price Target Cut: -3.67 (-1.70%)
On January 18, Barclays analyst Dan Levy made notable adjustments to the evaluation of Tesla, Inc., a major player in the electric vehicle and clean energy industry. Levy lowered Tesla, Inc. price target from $260 to $250 while maintaining an “Equal Weight” rating on the shares. Following this revision, the closing bell on January 18 witnessed a significant negative price reaction, with Tesla, Inc. experiencing a decline of 1.70%. Despite the reduction in the price target, the decision to maintain an “Equal Weight” rating suggests a balanced outlook, indicating that Tesla, Inc. is expected to perform in line with industry peers.
Tsai Capital Corporation stated the following regarding Tesla, Inc. in its fourth quarter 2023 investor letter:
“Tesla, Inc. (NASDAQ:TSLA) ($248.48 – up 101.7% for the year. Recent high $299.29): Tesla has significant and underappreciated competitive advantages across multiple verticals including electric vehicles, software and energy storage. Misunderstood by much of Wall Street – and consequently a favorite of short sellers – Tesla continues to grow rapidly and increase its lead over the competition while delighting consumers in the process. Despite his unconventional (and sometimes off-putting) personality, Elon Musk is a visionary who has created enormous shareholder value. Musk is also a long-term thinker who has embraced the scale-economies-shared business model favored by Henry Ford and Jeff Bezos, intentionally reducing prices, increasing the customer value proposition and expanding the total addressable market. Tesla’s massive scale and cost advantages are now challenging the viability of legacy auto, which has hundreds of billions of dollars of outdated property, plant and equipment in a world that is rapidly transitioning to electric vehicles (EVs). While we expect competition for EVs to intensify and for Tesla to lose market share over time, we also believe the company will increase production and deliveries from approximately 1.8 million vehicles today to approximately 15 million vehicles in 2030 and further its lead in autonomous driving capability. In fact, we expect Tesla will eventually license its autonomous driving software, creating high-margin (70-80%), recurring licensing revenue. Tesla is also one of only two companies that dominate the energy storage market, which has the potential to grow to several hundred billion in revenue as power plants around the world increase their focus on renewable energy. Our investment in Tesla is aligned with our preference for companies that have strong balance sheets and the managerial skill to reinvest capital at high rates of return into large addressable markets.”
02. Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Price Reaction after the Price Target Cut: -1.11 (-3.08%)
On January 18, HC Wainwright took significant steps to reassess the valuation of Halozyme Therapeutics, Inc. (NASDAQ:HALO), a key player in the biopharmaceutical industry. The financial firm lowered the price objective on Halozyme Therapeutics, Inc. from $61.00 to $48.00 while affirming a “buy” rating for the company. Following this adjustment, the closing bell on January 18 witnessed a substantial negative price reaction, with Halozyme Therapeutics, Inc. experiencing a decline of 3.08%. In the case of Halozyme Therapeutics, Inc., stakeholders may scrutinize how the company navigates challenges in the biopharmaceutical market, progresses with clinical developments, and strategically positions itself to understand the broader impact of the revised price objective.
Artisan Small Cap Fund made the following comment about Halozyme Therapeutics, Inc. in its second quarter 2023 investor letter:
“Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biotechnology firm with a unique technology platform that allows for the conversion of biologics and small molecule drugs administered intravenously into a subcutaneous formulation. This technology is licensed to pharmaceutical companies, which allows them to optimize their valuable therapies and Halozyme to generate predictable and durable royalties. In Q2, partner Johnson and Johnson announced the denial of a co-formulation patent for subcutaneous Darzalex in Europe. While this unfavorable news continued to impact Halozyme’s share price, we anticipate several value-generating catalysts in the second half. The first catalyst is FDA approval of Argenx’s VYVGART Hytrulo. This approval also benefits Halozyme as it is the subcutaneous enabler. The approval is due shortly after the quarter ends. We also expect clinical data for three more indications by year end, which will further expand the commercial opportunities for VYVGART and VYVGART Hytrulo. In addition, we are excited about the potential partnership opportunity with Argenx to develop Halozyme’s autoinjector. VYVGART’s potential as a multibillion-dollar drug, coupled with the dependence on Halozyme’s subcutaneous formulation platform and autoinjector pens, presents an important growth opportunity for Halozyme.”
01. biote Corp. (NASDAQ:BTMD)
Price Reaction after the Price Target Cut: -0.6300 (-13.6069%)
On January 18, Truist Financial made significant revisions to its evaluation of biote Corp. (NASDAQ:BTMD), a participant in the biotechnology sector. The financial institution lowered the target from $10.00 to $9.00 while maintaining a “Buy” recommendation. The current market price stands at $4.00, reflecting a notable change in market value, specifically a decline of 13.6% in response to the adjusted target. This development sheds light on the dynamic nature of the biotechnology sector, where financial analysts like Truist Financial are adapting their outlooks based on various considerations. Despite the reduction in the target, the decision to uphold a “Buy” recommendation suggests a positive outlook, indicating Truist Financial’s belief that biote Corp. may still present an attractive investment opportunity.
You can also take a look at 15 Best Innovative Stocks to Buy Now and 11 Best Natural Gas Dividend Stocks To Buy
Suggested articles:
- 15 Strongest Currencies in the World in 2024
- Billionaire Steve Cohen Aggressively Bought These 12 Stocks Recently
- 18 Most Profitable Value Stocks Now
This article is originally published at Insider Monkey.
